Modification of the Thioglycosyl–Naphthalimides as Potent and Selective Human O-GlcNAcase Inhibitors
作者:Shengqiang Shen、Lili Dong、Wei Chen、Xiangdi Zeng、Huizhe Lu、Qing Yang、Jianjun Zhang
DOI:10.1021/acsmedchemlett.8b00406
日期:2018.12.13
the synthesis of 13r bearing a 4-piperidylnaphthalimide moiety as a highly potent hOGA inhibitor (K i = 0.6 μM against hOGA) with good selectivity (K i > 100 μM against HsHexB). Furthermore, to investigate the basis for the potency and selectivity of 13r against hOGA, the possible inhibitory mechanisms of selected inhibitors (15b, 13b, and 13r) against hOGA and HsHexB were studied using molecular docking
β-N-乙酰己糖胺酶是广泛分布的糖苷外切酶,由于其在农药和药物发现领域的重要作用而引起了广泛的关注。值得注意的是,人O-GlcNAcase(hOGA)和人β-N-乙酰基己糖胺酶(HsHex)具有相同的催化机制,但在体内发挥不同的生理作用。在这封信中,我们旨在提高先前报道的巯基糖基萘二甲酰亚胺对hOGA的抑制力和选择性。合理的化合物设计导致合成了带有4-哌啶基萘二甲酰亚胺部分的13r,作为高效的hOGA抑制剂(针对hOGA的Ki = 0.6μM)和良好的选择性(针对HsHexB的Ki> 100μM)。此外,为研究13r对hOGA的效力和选择性的基础,以及所选抑制剂的可能抑制机制(15b,使用分子对接和MD模拟研究了针对hOGA和HsHexB的13b和13r)。这些4-取代的萘二甲酰亚胺硫代糖苷可能潜在地用作进一步研究hOGA功能的有用工具。